The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Muscarinic receptor subtypes in neuronal and non‐neuronal cholinergic function
Abstract
Summary: 1 Muscarinic M 1–M 5 receptors mediate the metabotropic actions of acetylcholine in the nervous system. A growing body of data indicate they also mediate autocrine functions of the molecule. The availability of novel and selective muscarinic agonists and antagonists, as well as in vivo gene disruption techniques, has clarified the roles of muscarinic receptors in mediating both functions of acetylcholine. 2 Selective M 1 agonists or mixed M 1 agonists/M 2 antagonists may provide an approach to the treatment of cognitive disorders, while M 3 antagonism, or mixed M 2/M 3 antagonists, are approved for the treatment of contractility disorders including overactive bladder and chronic obstructive pulmonary disease. Preclinical data suggest that selective agonism of the M 4 receptor will provide novel anti‐nociceptive agents, while therapeutics‐based upon agonism or antagonism of the muscarinic M 5 receptor have yet to be reported. 3 The autocrine functions of muscarinic receptors broadly fall into two areas – control of cell growth or proliferation and mediation of the release of chemical mediators from epithelial cells, ultimately causing muscle relaxation. The former particularly are involved in embryological development, oncogenesis, keratinocyte function and immune responsiveness. The latter regulate contractility of smooth muscle in the vasculature, airways and urinary bladder. 4 Most attention has focused on muscarinic M 1 or M 3 receptors which mediate lymphocyte immunoresponsiveness, cell migration and release of smooth muscle relaxant factors. Muscarinic M 4 receptors are implicated in the regulation of keratinocyte adhesion and M 2 receptors in stem cell proliferation and development. Little data are available concerning the M 5 receptor, partly due to the difficulties in defining the subtype pharmacologically. 5 The autocrine functions of acetylcholine, like those in the nervous system, involve activation of several muscarinic receptor subtypes. Consequently, the role of these subtypes in autocrine, as well neuronal cholinergic systems, significantly expands their importance in physiology and pathophysiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cholinergic hypothesis of Alzheimer’s disease: A review of progress
Francis, P. T., Palmer, A. M., Snape, M., & Wilcock, G. K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.137 · Cited by 2,198
International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors
Caulfield, M. P., & Birdsall, N. J. M. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01362-0 · Cited by 1,474
Acetylcholinesterase — new roles for an old actor
Soreq, H., & Seidman, S. (2001) · Nature Reviews Neuroscience · doi:10.1038/35067589 · Cited by 1,390
Hulme, E. C., Birdsall, N. J. M., & Buckley, N. J. (1990) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.30.040190.003221 · Cited by 1,338
Terry, A. V., & Buccafusco, J. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041616 · Cited by 1,159
Kubo, T., Fukuda, K., Mikami, A., Maeda, A., Takahashi, H., Mishina, M., Haga, T., Haga, K., Ichiyama, A., Kangawa, K., et al. (1986) · Nature · doi:10.1038/323411a0 · Cited by 906
Bartus, R. T. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7397 · Cited by 829
Muscarinic receptor subtypes and smooth muscle function
Eglen, R., Hegde, S., & Watson, N. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06957-1 · Cited by 544
Self-citationAndersson, K.-E., & Wein, A. J. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.4 · Cited by 484
Suh, Y.-H., & Checler, F. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.469 · Cited by 467
Matsui, M., Motomura, D., Karasawa, H., Fujikawa, T., Jiang, J., Komiya, Y., Takahashi, S.-I., & Taketo, M. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9579 · Cited by 450
Wessler, I., Kirkpatrick, C. J., & Racké, K. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00085-5 · Cited by 416
Muscarinic Acetylcholine Receptor Knockout Mice: Novel Phenotypes and Clinical Implications
Wess, J. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121622 · Cited by 380
Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean
Yamada, M., Miyakawa, T., Duttaroy, A., Yamanaka, A., Moriguchi, T., Makita, R., Ogawa, M., Chou, C. J., Xia, B., Crawley, J. N., et al. (2001) · Nature · doi:10.1038/35065604 · Cited by 373
Neurotransmitters as early signals for central nervous system development
Nguyen, L., Rigo, J.-M., Rocher, V., Belachew, S., Malgrange, B., Rogister, B., Leprince, P., & Moonen, G. (2001) · Cell and Tissue Research · doi:10.1007/s004410000343 · Cited by 371
The lymphocytic cholinergic system and its contribution to the regulation of immune activity
Kawashima, K., & Fujii, T. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.09.037 · Cited by 326
Wessler, I., Kirkpatrick, C., & Racké, K. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03016.x · Cited by 303
Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes.
Gutkind, J. S., Novotny, E. A., Brann, M. R., & Robbins, K. C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4703 · Cited by 291
The non-neuronal cholinergic system in humans: Expression, function and pathophysiology
Wessler, I., Kilbinger, H., Bittinger, F., Unger, R., & Kirkpatrick, C. J. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00083-3 · Cited by 278
Yamada, M., Lamping, K. G., Duttaroy, A., Zhang, W., Cui, Y., Bymaster, F. P., McKinzie, D. L., Felder, C. C., Deng, C.-X., Faraci, F. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251542998 · Cited by 275
Human Keratinocytes Synthesize, Secrete, and Degrade Acetylcholine
Grando, S. A., Kist, D. A., Qi, M., & Dahl, M. V. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12358588 · Cited by 271
Vilaró, M. T., Palacios, J., & Mengod, G. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90064-g · Cited by 268
Kawashima, K. (2004) · Frontiers in Bioscience · doi:10.2741/1390 · Cited by 259
Autonomic neural regulation of immunity
CZURA, C. J., & TRACEY, K. J. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01442.x · Cited by 255
Biological Functions of Keratinocyte Cholinergic Receptors
Grando, S. A. (1997) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/jidsymp.1997.10 · Cited by 242
Regulation of muscarinic acetylcholine receptor signaling
van Koppen, C. J., & Kaiser, B. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00032-9 · Cited by 239
Therapeutic Opportunities for Muscarinic Receptors in the Central Nervous System
Felder, C. C., Bymaster, F. P., Ward, J., & DeLapp, N. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990607u · Cited by 235
Song, P., Sekhon, H. S., Jia, Y., Keller, J. A., Blusztajn, J. K., Mark, G. P., & Spindel, E. R. (2003) · PubMed · Cited by 234
Progress in Medicinal Chemistry.
Burger, A. (1963) · Journal of Medicinal Chemistry · doi:10.1021/jm00342a061 · Cited by 231
Polyspecific Cation Transporters Mediate Luminal Release of Acetylcholine from Bronchial Epithelium
Lips, K. S., Volk, C., Schmitt, B. M., Pfeil, U., Arndt, P., Miska, D., Ermert, L., Kummer, W., & Koepsell, H. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0363oc · Cited by 221
Mansfield, K. J., Liu, L., Mitchelson, F. J., Moore, K. H., Millard, R. J., & Burcher, E. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706147 · Cited by 213
Eiden, L. E. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70062227.x · Cited by 207
Ultrastructural localization of choline acetyltransferase in vascular endothelial cells in rat brain
Parnavelas, J. G., Kelly, W., & Burnstock, G. (1985) · Nature · doi:10.1038/316724a0 · Cited by 206
Evolutional study on acetylcholine expression
Horiuchi, Y., Kimura, R., Kato, N., Fujii, T., Seki, M., Endo, T., Kato, T., & Kawashima, K. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02478-5 · Cited by 203
Proskocil, B. J., Sekhon, H. S., Jia, Y., Savchenko, V., Blakely, R. D., Lindstrom, J., & Spindel, E. R. (2004) · Endocrinology · doi:10.1210/en.2003-1728 · Cited by 200
Have cholinergic therapies reached their clinical boundary in Alzheimer's disease?
Jones, R. W. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.936 · Cited by 197
Basile, A. S., Fedorova, I., Zapata, A., Liu, X., Shippenberg, T., Duttaroy, A., Yamada, M., & Wess, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162371899 · Cited by 195
The Non-neuronal Cholinergic System: an Emerging Drug Target in the Airways
Wessler, I. K., & Kirkpatrick, C. J. (2001) · Pulmonary Pharmacology & Therapeutics · doi:10.1006/pupt.2001.0313 · Cited by 185
Muscarinic regulation of cardiac ion channels
Harvey, R. D., & Belevych, A. E. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705338 · Cited by 175
Cellular Signaling Mechanisms for Muscarinic Acetylcholine Receptors
Lanzafame, A. A., Christopoulos, A., & Mitchelson, F. J. (2003) · Receptors and Channels · doi:10.3109/10606820308263 · Cited by 174
Fisher, A., Pittel, Z., Haring, R., Bar-Ner, N., Kliger-Spatz, M., Natan, N., Egozi, I., Sonego, H., Marcovitch, I., & Brandeis, R. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:349 · Cited by 173
The airway cholinergic system: physiology and pharmacology
Racké, K., & Matthiesen, S. (2004) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2004.03.001 · Cited by 154
Wessler, I. K., Roth, E., Deutsch, C., Brockerhoff, P., Bittinger, F., Kirkpatrick, C. J., & Kilbinger, H. J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704335 · Cited by 152
Human placental cholinergic system
Sastry, B. V. R., Olubadewo, J. O., Harbison, R. D., & Schmidt, D. E. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90345-2 · Cited by 152
Duttaroy, A., Gomeza, J., Gan, J.-W., Siddiqui, N., Basile, A. S., Harman, W. D., Smith, P. L., Felder, C. C., Levey, A. I., & Wess, J. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1084 · Cited by 141
Phenotypical and Molecular Profiling of the Extraneuronal Cholinergic System of the Skin
Kurzen, H., Berger, H., Jäger, C., Hartschuh, W., Näher, H., Gratchev, A. N., Goerdt, S., & Deichmann, M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23425.x · Cited by 132
Zia, S., Ndoye, A., Lee, T. X., Webber, R. J., & Grando, S. A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39322-x · Cited by 132
Sarno, P. D., Shestopal, S. A., King, T. D., Zmijewska, A. A., Song, L., & Jope, R. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212157200 · Cited by 132
Elhusseiny, A., & Hamel, É. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200002000-00011 · Cited by 131
Allosterism at Muscarinic Receptors: Ligands and Mechanisms
Birdsall, N. J. M., & Lazareno, S. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557054023251 · Cited by 126
Ndoye, A., Buchli, R., Greenberg, B. M., Nguyen, V. T., Zia, S., Lawry, M. A., Grando, S. A., Rodriguez, J. G., & Webber, R. J. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00299.x · Cited by 124
The muscarinic M 5 receptor: a silent or emerging subtype?
Eglen, R. M., & Nahorski, S. R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703276 · Cited by 121
Self-citationALLOSTERIC INTERACTIONS AT MUSCARINIC CHOLINOCEPTORS
Christopoulos, A., Lanzafame, A. A., & Mitchelson, F. J. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.t01-4-.x · Cited by 113
Human placental cholinergic system
Sastry, B. V. R. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00017-8 · Cited by 110
Wess, J., Duttaroy, A., Zhang, W., Gomeza, J., Cui, Y., Miyakawa, T., Bymaster, F. P., Mckinzie, L., Felder, C. C., Lamping, K. G., et al. (2003) · Receptors and Channels · doi:10.3109/10606820308262 · Cited by 108
Lazareno, S., Doležal, V., Popham, A., & Birdsall, N. J. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.1.257 · Cited by 104
Muscarinic mechanisms in nerve cells
Brown, D. A., Abogadie, F. C., Allen, T. G. J., Buckley, N. J., Caulfield, M. P., Delmas, P., Haley, J. E., Lamas, J. A., & Selyanko, A. A. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00058-1 · Cited by 101
Increased acetylcholine levels in skin biopsies of patients with atopic dermatitis
Wessler, I. K., Reinheimer, T. M., Kilbinger, H. J., et al. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00079-1 · Cited by 98
Expression and function of the non-neuronal cholinergic system in endothelial cells.
Kirkpatrick, C., Bittinger, F., Nozadze, K., & Wessler, I. (2003) · Life Science · doi:10.1016/s0024-3205(03)00069-9 · Cited by 98
Heterogeneity of vascular muscarinic receptors
Eglen, R. M., & Whiting, R. L. (1990) · Journal of Autonomic Pharmacology · doi:10.1111/j.1474-8673.1990.tb00023.x · Cited by 97
Self-citationAndersen, M. B., Fink‐Jensen, A., Peacock, L., Gerlach, J., Bymaster, F. P., Lundbæk, J. A., & Werge, T. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300151 · Cited by 95
Pharmacologic therapy for the irritable bowel syndrome
Talley, N. J. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07306.x · Cited by 94
Gerthoffer, W. T. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00530.2004 · Cited by 93
Chernyavsky, A. I., Arredondo, J., Wess, J., Karlsson, E., & Grando, S. A. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200401034 · Cited by 92
Jiménez, E. G., & Montiel, M. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20326 · Cited by 90
Oki, T., Takagi, Y., Inagaki, S., Taketo, M. M., Manabe, T., Matsui, M., & Yamada, S. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.012 · Cited by 89
Acetylcholine synthesis and muscarinic receptor subtype mRNA expression in T-lymphocytes
Kawashima, K., Fujii, T., Watanabe, Y., & Misawa, H. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00131-3 · Cited by 89
Nguyen, V. T., Chernyavsky, A. I., Arredondo, J., Bercovich, D., Orr‐Urtreger, A., Vetter, D. E., Wess, J., Beaudet, A. L., Kitajima, Y., & Grando, S. A. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.12.010 · Cited by 85
Neuroprotective strategies in Alzheimer’s disease
Longo, F. M., & Massa, S. M. (2004) · NeuroRx · doi:10.1602/neurorx.1.1.117 · Cited by 83
Schmidt, M., Voß, M., Weernink, P. A. O., Wetzel, J., Amano, M., Kaibuchi, K., & Jakobs, K. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.14648 · Cited by 83
Relationship between α7 nAChR and apoptosis in human lymphocytes
Rosa, M. J. D., Esandi, M. D. C., Garelli, A., Rayes, D., & Bouzat, C. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.11.010 · Cited by 81
Novel aspects in cutaneous biology of acetylcholine synthesis and acetylcholine receptors
Kurzen, H., & Schallreuter, K. U. (2004) · Experimental Dermatology · doi:10.1111/j.1600-0625.2004.00258.x · Cited by 80
Reinheimer, T. M., Bernedo, P., Klapproth, H., Oelert, H., Zeiske, B., Racké, K., & Wessler, I. (1996) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1996.270.5.l722 · Cited by 79
Regulation of CD8+ cytolytic T lymphocyte differentiation by a cholinergic pathway
Zimring, J. C., Kapp, L. M., Yamada, M., Wess, J., & Kapp, J. A. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.03.018 · Cited by 78
Collison, D. J., Coleman, R. A., James, R. S., Carey, J. E., & Duncan, G. (2000) · PubMed · Cited by 76
Fritz, S., Wessler, I. K., Rainer Breitling, A., Rossmanith, W. G., Ojeda, S. R., Dissen, G. A., Amsterdam, A., & Mayerhofer, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7146 · Cited by 76
Synthesis of acetylcholine by lung cancer
Song, P., Sekhon, H. S., Proskocil, B. J., Blusztajn, J. K., Mark, G. P., & Spindel, E. R. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00078-x · Cited by 74
Growth-promoting effect of muscarinic acetylcholine receptors in colon cancer cells
Ukegawa, J.-I., Takeuchi, Y., Kusayanagi, S., & Mitamura, K. (2003) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0433-y · Cited by 74
Ibáñez, C. F., Pelto‐Huikko, M., Söder, O., Ritzén, E. M., Hersh, L. B., Hökfelt, T. G. M., & Persson, H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3676 · Cited by 71
Development of Muscarinic Analgesics Derived from Epibatidine: Role of the M4 Receptor Subtype
Ellis, J. L., Harman, D., González‐Gallego, J., Spera, M. L., Liu, R., Shen, T. Y., Wypij, D. M., & Zuo, F. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38067-x · Cited by 71
Slutsky, I., Wess, J., Gomeza, J., Dudél, J., Parnas, I., & Parnas, H. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00668.2002 · Cited by 60
Wang, H., Ng, K. K. Y., Hayes, D. J., Gao, X., Forster, G. L., Blaha, C. D., & Yeomans, J. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300502 · Cited by 60
Vasodilatory effects of cholinergic agonists are greatly diminished in aorta from M3R−/− mice
Khurana, S., Chacon, I. M., Xie, G., Yamada, M., Wess, J., Raufman, J., & Kennedy, R. H. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.04.012 · Cited by 56
Cholinergic dysfunction in vascular dementia
Román, G. C. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0019-2 · Cited by 55
Regional development of muscarinic cholinergic binding sites in the prenatal rat brain
Schlumpf, M., Palacios, J. M., Cortés, R., & LICHTENSTEIGER, W. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90232-d · Cited by 55
G-protein–gated TRP-like Cationic Channel Activated by Muscarinic Receptors
Zholos, A. V., Zholos, A. A., & Bolton, T. B. (2004) · The Journal of General Physiology · doi:10.1085/jgp.200309002 · Cited by 55
Leloup, C., Michaelson, D. M., Fisher, A., Hartmann, T., Beyreuther, K. T., & Stein, R. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400713 · Cited by 55
Teaktong, T., Piggott, M. A., McKeith, I. G., Perry, R. H., Ballard, C. G., & Perry, E. K. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.02.019 · Cited by 54
Signalling of the M3-muscarinic receptor to the anti-apoptotic pathway
Budd, D. C., Spragg, E. J., Ridd, K., & Tobin, A. B. (2004) · Biochemical Journal · doi:10.1042/bj20031705 · Cited by 50
New Trends in the Design of Drugs Against Alzheimer's Disease
Francotte, P., Graindorge, E., Boverie, S., Tullio, P. D., & Pirotte, B. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043364946 · Cited by 48
Zhou, C., Wen, Z., Shi, D., & Xie, Z. (2004) · Cell Biology International · doi:10.1016/j.cellbi.2003.10.005 · Cited by 47
Expression of the cholinergic gene locus in pulmonary arterial endothelial cells
Haberberger, R. V., Bodenbenner, M., & Kummer, W. (2000) · Histochemistry and Cell Biology · doi:10.1007/s004180000153 · Cited by 46
Chen, S.-R., Wess, J., & Pan, H. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.082537 · Cited by 44
Arredondo, J., Hall, L. L., Ndoye, A., Chernyavsky, A. I., Jolkovsky, D. L., & Grando, S. A. (2003) · Journal of Periodontal Research · doi:10.1034/j.1600-0765.2003.01006.x · Cited by 41
Acetylcholine synthesis and neuron differentiation
Biagioni, S., Tata, A. M., Jaco, A. D., & Augusti-Tocco, G. (2000) · The International Journal of Developmental Biology · doi:10.1387/ijdb.11061433 · Cited by 37
Williams, C. L., & Lennon, V. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40035-5 · Cited by 34
Ma, W., Li, B., Zhang, L., & Pant, H. C. (2004) · Drug News & Perspectives · doi:10.1358/dnp.2004.17.4.829053 · Cited by 33
de la Torre, E., Davel, L., Jasnis, M. A., et al. (2005) · Breast Cancer Research · doi:10.1186/bcr1005 · Cited by 32
Sailer, M., Oppitz, M., & Drews, U. (2000) · Anatomy and Embryology · doi:10.1007/pl00008226 · Cited by 30
Fujii, T., Watanabe, Y., Kawashima, K., & Fujimoto, K. (2002) · Biogenic Amines · doi:10.1163/15693910260698320 · Cited by 30
Cholinergic muscarinic binding by rat lymphocytes: Effects of antagonist treatment, strain and aging
Shenkman, L., Rabey, J. M., & Gilad, G. M. (1986) · Brain Research · doi:10.1016/0006-8993(86)90226-x · Cited by 26
Muscarinic signaling in carcinoma cells
Williams, C. L. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00080-8 · Cited by 26
Localization of the m5 muscarinic cholinergic receptor in rat circle of Willis and pial arteries
Tayebati, S. K., Tullio, M. A. D., Tomassoni, D., et al. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00513-x · Cited by 25
Sheardown, M. J. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.6.863 · Cited by 23
Williams, B. P., Milligan, C. J., Street, M., Hornby, F., Deuchars, J., & Buckley, N. J. (2003) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02117.x · Cited by 22
Mucocutaneous cholinergic system is targeted in mustard-induced vesication
Grando, S. A. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00074-2 · Cited by 21
Cholinergic Stimulation of Human Microcitoma Cell Line H69
Fucile, S., Napolitano, M., & Mattei, E. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.5994 · Cited by 21
Oda, Y., Muroishi, Y., Misawa, H., & Suzuki, S. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.002 · Cited by 19
Kubera, M., SKOWRON-CENDRZAK, A., Mazur‐Kolecka, B., Bubak-Satora, M., Basta‐Kaim, A., Laskowska-Bożek, H., & Ryżewski, J. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90007-8 · Cited by 17
Neuronal nicotinic acetylcholine receptors: not just in brain
Spindel, E. R. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00251.2003 · Cited by 13
Rabey, J. M., Shenkman, E. A., & Gilad, G. M. (1986) · Advances in behavioral biology · doi:10.1007/978-1-4613-2179-8_42 · Cited by 4
Cited by
Acetylcholine beyond neurons: the non‐neuronal cholinergic system in humans
Wessler, I., & Kirkpatrick, C. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.185 · Cited by 855
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
Wess, J., Eglen, R. M., & Gautam, D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2379 · Cited by 637
Self-citationThe cholinergic system and Parkinson disease
Bohnen, N. I., & Albin, R. L. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.048 · Cited by 566
Muscarinic receptor antagonists for overactive bladder
Abrams, P., & Andersson, K. (2007) · BJU International · doi:10.1111/j.1464-410x.2007.07205.x · Cited by 405
The muscarinic system, cognition and schizophrenia
Carruthers, S. P., Gurvich, C. T., & Rossell, S. L. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.011 · Cited by 90
Metadata
- Authors
- Eglen, R. M.
- Venue
- Autonomic and Autacoid Pharmacology
- Publisher
- Wiley
- Published
- 2006-06-19
- Volume
- 26
- Issue
- 3
- Pages
- 219-233
- ISSN
- 1474-8665 (ISSN-L)
- 1474-8673
- OpenAlex
- W2121629043
- Cited by
- 311
- References
- 111
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.